Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 3:26 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1753–1776 of 6,923 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Stimulation Clear all

Conditions: Parkinson Disease, Idiopathic, Parkinson Disease
Interventions: Deep brain stimulation; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Nasogastric Tube Intubation
Interventions: Vagal Nerve Stimulator, Placebo Vagal Nerve Stimulator; Device
Lead sponsor: Jacques E. Chelly; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Freezing of Gait Symptoms in Parkinson Disease
Interventions: Active Stimulation, Sham (No Treatment); Device
Lead sponsor: Iahn Cajigas; Other
Eligibility: 35 Years to 80 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 3
States / cities: San Francisco, California • Miami, Florida • Philadelphia, Pennsylvania

Conditions: Stroke, Stroke Sequelae, Motor Activity
Interventions: Transcranial Magnetic Stimulation, transcutaneous auricular vagus nerve stimulation (taVNS); Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Transcranial Magnetic Stimulation
Interventions: transcranial magnetic stimulation; Device
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Tallahassee, Florida

Conditions: Mild Cognitive Impairment, Alzheimer's Disease
Interventions: Transcranial direct current stimulation (tDCS) Soterix Medical Inc. tDCS unit; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 50 Years to 88 Years
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
Interventions: anti-thymocyte globulin, filgrastim, busulfan, cyclophosphamide, cyclosporine, methylprednisolone, bone marrow ablation with stem cell support, umbilical cord blood transplantation, radiation therapy; Biological · Drug · Procedure + 1 more
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: 5 Years to 50 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2017
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Tinnitus
Interventions: Deep Brain Stimulation (DBS); Device
Lead sponsor: Paul Larson; Other
Eligibility: 22 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Epilepsy Intractable
Interventions: Transcranial magnetic stimulation; Device
Lead sponsor: Aaron Boes; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Stroke, Cerebrovascular Accident (CVA), Hemiparesis, Spasticity as Sequela of Stroke, Muscle Spasticity, Upper Extremity Paralysis
Interventions: sham Doublestim, anodal Doublestim; Device
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Essential Tremor, Parkinson Disease, Dystonia
Interventions: Active biphasic pulse stimulation---Home Settings, Active biphasic pulse stimulation---VIN Biphasic, Active biphasic pulse stimulation---Stimulator Off; Device
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 80 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Gainesville, Florida

Conditions: HIV Infections
Interventions: Hepatitis B virus vaccine with GM-CSF adjuvant, Hepatitis B virus vaccine; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2008
U.S. locations: 11
States / cities: Chicago, Illinois • St Louis, Missouri • New York, New York + 6 more

Conditions: Restless Legs Syndrome
Interventions: NTX100 Neuromodulation System - Active, NTX100 Neuromodulation System - Sham, NTX100 Neuromodulation System - Open-Label; Device
Lead sponsor: Noctrix Health, Inc.; Industry
Eligibility: 22 Years to 79 Years
Enrollment: 133 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 7
States / cities: San Leandro, California • Colorado Springs, Colorado • Atlanta, Georgia + 4 more

Conditions: Stroke, Shoulder Pain
Interventions: Peripheral Nerve Stimulation; Device
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: 21 Years to 89 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Long COVID, Long COVID Syndrome, Long COVID-19 Syndrome, PASC, PASC Post Acute Sequelae of COVID 19
Interventions: accelerated intermittent theta burst stimulation; Device
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Chronic Pain, Post Traumatic Stress Disorder (PTSD)
Interventions: Transcranial Direct Current Stimulation (tDCS), Massed-Prolonged Exposure (PE), Sham Transcranial Direct Current Stimulation (tDCS); Device · Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 21 Years and older
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Charleston, South Carolina • Houston, Texas

Conditions: Pneumonia, Sinusitis, Bronchitis, Respiratory Disease, Respiratory Tract Infections
Interventions: Lymphatic Pump Osteopathic Manipulative Therapy; Procedure
Lead sponsor: Geisinger Clinic; Other
Eligibility: 65 Years to 100 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Bloomsburg, Pennsylvania

Conditions: Genito-Pelvic Pain/Penetration Disorder, Dyspareunia, Vaginismus, Pelvic Pain, Vestibulodynia, Vulvodynia (Chronic Vulvar Pain)
Interventions: Pelvic floor therapy; Device
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Chronic Graft-versus-host-disease
Interventions: axatilimab; Drug
Lead sponsor: Syndax Pharmaceuticals; Industry
Eligibility: 6 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 11
States / cities: Birmingham, Alabama • Duarte, California • Miami, Florida + 8 more

Conditions: Graves' Disease
Interventions: IMVT-1402; Drug
Lead sponsor: Immunovant Sciences GmbH; Industry
Eligibility: 18 Years and older
Enrollment: 372 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 89
States / cities: Phoenix, Arizona • Tucson, Arizona • Concord, California + 75 more

Conditions: Pain Management, Peripheral Neuropathic Pain
Interventions: Cold Pressor Task - Upper Limb, Algometry Pain Tests in the Upper Limb, Algometry Pain Tests in the Lower Limb; Device
Lead sponsor: Evan (Huiliang) Wang; Other
Eligibility: 20 Years to 40 Years
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Spinal Cord Stimulation, Chronic Pain
Interventions: Spinal Cord Stimulation; Device
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Infertility
Interventions: intrauterine insemination, in vitro fertilization; Procedure
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 38 Years to 43 Years
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2013
U.S. locations: 4
States / cities: Boston, Massachusetts • Brookline, Massachusetts • Quincy, Massachusetts + 1 more

Conditions: Stroke
Interventions: Transcranial direct current stimulation (high-definition); Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 90 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Search by objective public record fields.

LFP Sensing From Directional Leads in the Acute Clinical Setting

Vagal Stimulator to Reduce Nasogastric Tube Use

CnF-DBS for Levodopa-Resistant FOG

Noninvasive VNS to Facilitate Excitability in Motor Cortex

iTBS/fMRI Study of Hierarchical Control in the PFC

Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

Pilot Study of Deep Brain Stimulation (DBS) in Area LC for Chronic Tinnitus

TMS - Intracranial Electrodes

The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke

Physiology, Imaging and Modeling of Essential Tremor

Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals

Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study)

Peripheral Nerve Stimulation for Shoulder Pain: Dose Response

Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation

Neuromodulation + Prolonged Exposure Therapy: Evaluation of a Technology-Enhanced, Integrated Treatment for Pain and PTSD

How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.

VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia

A Phase 1/2 Study to Evaluate Axatilimab in Participants With Active cGVHD

A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)

Wearable Focused Ultrasound Stimulation for Peripheral Nerve Pain Management

Epigenetic Mechanisms and Symptom Clusters Associated with Resolution of Pain Following Spinal Cord Stimulation

Infertility Therapy for Women Age Thirty-eight and Older

Targeted High-definition Transcranial Direct Current Stimulation (HD-tDCS) for Reducing Post-stroke Movement Impairments